6 results
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Each class of medications ... effect on weight ... #pharmacology #pharmacotherapy ... #table #comparison ... #diabetes #endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient Medication ... Guide Classes ... #pharmacology # ... comparison #table ... #endocrinology
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... not definitively cause ... /effect) • Saxagliptin ... DPP4 #Inhibitors #Pharmacology ... DM2 #diabetes #endocrinology
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... Ozempic), or daily tablet ... not definitively cause ... /effect) • May ... DM2 #diabetes #endocrinology
Pituitary Mass Effects - Pathogenesis and Clinical Findings
 • Pituitary turnors are almost always a benign
affect approximately ... For pituitary masses ... targeted with medication ... #SideEffects #endocrinology ... mnemonic #GLFTAP #pathophysiology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
semaglutide, the same medication ... drug to remain stable ... take any other medications ... semaglutide #Diabetes #Pharmacology ... #Endocrinology